Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,258,526
+$527,519 QoQ
Shares Held
1,883
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#2,380
of 4,604 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mezzasalma Advisors, LLC holds $4,153,666 across 4 Drug Manufacturers - General names. LLY ranks #1 (54.4% of the industry book) .
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,258,526 | 1,883 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,731,007 | 1,882 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $5,080,012 | 4,727 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $4,093,495 | 5,365 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $4,771,503 | 6,121 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $5,900,301 | 7,144 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $6,202,248 | 8,034 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $7,701,476 | 8,693 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $7,692,108 | 8,496 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $4,856,804 | 6,243 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,730,106 | 2,968 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||